Pharming Group N.V.
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $72,447 | $106,421 | $97,287 | $93,221 |
Gross Profit | 65,803 | 82,133 | 90,216 | 84,249 |
EBITDA | 1,058 | 5,202 | 23,430 | 9,785 |
EBIT | -2,058 | 1,998 | 20,704 | 7,083 |
Net Income | -5,213 | 5,296 | 7,548 | 4,694 |
Net Change In Cash | 72,447 | 106,421 | 97,287 | 93,221 |
Free Cash Flow | 1,388 | 7,121 | 29,941 | 11,615 |
Cash | 53,104 | 146,021 | 112,752 | 94,817 |
Basic Shares | 70,140 | 75,766 | 66,904 | 66,904 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $377,182 | $307,747 | $245,316 | $205,622 |
Gross Profit | 331,555 | 271,092 | 220,104 | 188,060 |
EBITDA | 30,615 | 16,894 | 9,877 | 33,533 |
EBIT | 19,367 | 253 | -6,048 | 20,345 |
Net Income | 2,858 | -12,261 | -10,548 | 13,674 |
Net Change In Cash | 377,182 | 307,747 | 245,316 | 205,622 |
Free Cash Flow | 49,314 | -2,682 | -18,766 | 20,481 |
Cash | 146,021 | 56,893 | 61,741 | 207,342 |
Basic Shares | 71,317 | 68,918 | 65,702 | 84,284 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.07 |
2025-12-31 | $0.07 |
2025-09-30 | $0.10 |
2025-06-30 | $0.01 |